Innovation1 Biotech Inc.
IVBT
$0.0002
-$0.0006-75.00%
OTC PK
| 11/30/2023 | 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.80K | 49.80K | 76.70K | 52.50K | 11.30K |
| Total Receivables | -- | 7.90K | 56.40K | 56.40K | 56.40K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 11.30K | 15.00K | 29.80K | 33.10K | 53.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 17.10K | 72.70K | 162.90K | 142.00K | 120.70K |
|
|
|||||
| Total Current Assets | 17.10K | 72.70K | 162.90K | 142.00K | 120.70K |
| Net Property, Plant & Equipment | 1.30K | 1.60K | 1.80K | 2.10K | 432.80K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.70K | 1.70K | 3.38M | 3.38M | 3.38M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 310.00K | 310.00K | 310.00K |
| Total Assets | 20.10K | 76.00K | 3.86M | 3.84M | 4.25M |
|
|
|||||
| Total Accounts Payable | 357.30K | 349.30K | 305.90K | 317.80K | 204.20K |
| Total Accrued Expenses | 269.10K | 1.18M | 646.60K | 697.70K | 459.90K |
| Short-term Debt | 50.00K | 10.00K | 10.00K | 10.00K | 10.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | 204.20K |
| Total Finance Division Other Current Liabilities | 1.98M | 1.75M | 1.53M | 1.31M | 1.04M |
| Total Other Current Liabilities | 1.98M | 1.75M | 1.53M | 1.31M | 1.04M |
| Total Current Liabilities | 2.66M | 3.29M | 2.49M | 2.34M | 1.91M |
|
|
|||||
| Total Current Liabilities | 2.66M | 3.29M | 2.49M | 2.34M | 1.91M |
| Long-Term Debt | 414.60K | 219.00K | 110.80K | 22.40K | 2.70K |
| Short-term Debt | 50.00K | 10.00K | 10.00K | 10.00K | 10.00K |
| Capital Leases | -- | -- | -- | -- | 245.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.07M | 3.51M | 2.60M | 2.36M | 2.16M |
|
|
|||||
| Common Stock & APIC | 55.99M | 55.19M | 55.19M | 54.90M | 47.45M |
| Retained Earnings | -59.05M | -58.63M | -53.95M | -53.43M | -45.37M |
| Treasury Stock & Other | -- | -- | 0.00 | -- | -- |
| Total Common Equity | -3.06M | -3.44M | 1.24M | 1.47M | 2.08M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 8.10K | 8.10K | 8.10K | 8.10K | 8.10K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 8.10K | 8.10K | 8.10K | 8.10K | 8.10K |
|
|
|||||
| Total Common Equity | -3.06M | -3.44M | 1.24M | 1.47M | 2.08M |
| Total Preferred Equity | 8.10K | 8.10K | 8.10K | 8.10K | 8.10K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.05M | -3.43M | 1.25M | 1.48M | 2.08M |
|
|
|||||